How mRNA Vaccines Rarely Cause Myocarditis?
In 2021, amidst the peak of the global COVID-19 vaccination campaign, a rare safety signal emerged that captured the attention of the medical community. Researchers from Israel and the United States were the first to identify and report a correlation between mRNA vaccines (Pfizer-BioNTech and Moderna) and the onset of myocarditis, particularly in young males.
A new study conducted at Stanford Medicine offers the first detailed molecular explanation for this phenomenon. According to the study's findings, in the rare instances where myocarditis occurs, the vaccine triggers a specific inflammatory cascade. Immune cells known as macrophages absorb the mRNA vaccine but respond with excessive aggression. These hyper-activated macrophages release massive amounts of two specific inflammatory proteins (cytokines): CXCL10 and Interferon-gamma (IFN-γ). These cytokines circulate through the bloodstream to the heart tissue, where they cause direct damage and inflammation. In experiments utilizing human heart tissues grown in the lab (organoids) and murine models, the researchers demonstrated that blocking CXCL10 or neutralizing Interferon-gamma completely prevented myocardial damage and the development of myocarditis, without compromising the vaccine's efficacy in generating neutralizing antibodies against COVID-19.
